Imunon (IMNN) said Friday it received positive data showing improvement in overall and progression-free survival from a phase 2 study of IMNN-001, an investigational therapy for the treatment of advanced ovarian cancer.
Shares more than doubled as intraday trading volume catapulted to over 330.6 million from a daily average of about 532,000.
Merus (MRUS) shares soared 36% amid heavy trading after the company reported favorable interim cancer trial results overnight.
Over 5.63 million shares traded intraday versus a daily average of roughly 836,000.
Douglas Elliman (DOUG) has received a merger offer from Anywhere Real Estate (HOUS) this week that would value the company at roughly double its current share price, Bloomberg reported Friday, citing people with knowledge of the matter.
Shares soared 33%, with intraday trading volume at nearly 12 million compared with a daily average of roughly 543,000.
Price: 1.10, Change: +0.68, Percent Change: +164.74
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.